Clinical Trials Directory

Trials / Unknown

UnknownNCT05949411

Development of Non-invasive Methods to Study Gut Microbiome - Nutrition - Host Interactions

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Université Catholique de Louvain · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to develop and validate an adequate protocol of volatolome (volatile metabolites) measurement in breath of human volunteers (18-65 years) to study gut microbiome - nutrition - host interactions in a general healthy population. For this purpose, breath volatile metabolites (BVM) will be analyzed throughout test days in fasting state and after standardized meals using selected ion flow tube mass spectrometry (SIFT-MS). In addition, gut microbial functions linked notably to hydrogen/methane production, carbohydrates utilization (CAZymes), and in the production of other volatile metabolites of interest (i.e. indole, fatty acid derivatives, ...) will be unraveled through microbiome sequencing data analysis (in silico), metabolomic analyses and measurement of enzymatic activities from saliva, urine and/or fecal samples.

Conditions

Interventions

TypeNameDescription
OTHERScreening visitSubjects will be invited to perform the screening visit to sign the informed consent and then to ensure that they are able to participate in this study.
OTHERLactulose testFasted subjects (at least 10 hours) will receive on oral load of 10 g of lactulose. Then, exhaled H2 will be measured every 30 minutes during 4 hours.
OTHERAdministration of standardized meals with characterized dietary fiber contentSubjects will receive standardized breakfasts and lunches characterized in terms of dietary fiber content. Urine, saliva, feces samples will be collected. Breath test and gastrointestinal symptoms will be followed during maximum 8h. Subjects will also complete SF36 questionnaire, food diary and stool/transit questionnaire.

Timeline

Start date
2023-07-01
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2023-07-18
Last updated
2023-07-18

Locations

3 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05949411. Inclusion in this directory is not an endorsement.